655 related articles for article (PubMed ID: 20108376)
1. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
Linder J; Stenlund H; Forsgren L
Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.
Winter Y; Bezdolnyy Y; Katunina E; Avakjan G; Reese JP; Klotsche J; Oertel WH; Dodel R; Gusev E
Mov Disord; 2010 Feb; 25(3):349-56. PubMed ID: 20108378
[TBL] [Abstract][Full Text] [Related]
3. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
4. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
5. How do patients with parkinsonism present? A clinicopathological study.
Williams DR; Lees AJ
Intern Med J; 2009 Jan; 39(1):7-12. PubMed ID: 18422568
[TBL] [Abstract][Full Text] [Related]
6. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
Williams DR; Lees AJ
Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
[TBL] [Abstract][Full Text] [Related]
10. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
[TBL] [Abstract][Full Text] [Related]
12. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
[TBL] [Abstract][Full Text] [Related]
14. New and reliable MRI diagnosis for progressive supranuclear palsy.
Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
[TBL] [Abstract][Full Text] [Related]
15. Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.
Stamelou M; Christ H; Reuss A; Oertel W; Höglinger G
Mov Disord; 2011 Apr; 26(5):901-5. PubMed ID: 21384428
[TBL] [Abstract][Full Text] [Related]
16. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
Williams DR; Warren JD; Lees AJ
J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):652-5. PubMed ID: 17872984
[TBL] [Abstract][Full Text] [Related]
17. Anal sphincter EMG in the diagnosis of parkinsonian syndromes.
Winge K; Jennum P; Lokkegaard A; Werdelin L
Acta Neurol Scand; 2010 Mar; 121(3):198-203. PubMed ID: 19785640
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Wenning GK; Colosimo C
Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
[TBL] [Abstract][Full Text] [Related]
19. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
[TBL] [Abstract][Full Text] [Related]
20. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
